In March 2016 more than 40 participants from across Canada came together to discuss the research needed to support the most effective possible implementation and use of pre-exposure prophylaxis (PrEP) therapies for HIV. The meeting was funded by REACH 2.0 and sponsored by four HIV research funders: CANFAR, CTN, OHTN, and REACH 2.0.
The report lists priorities identified at the meeting for a national program of research along with next steps to address this research agenda.
Download a PDF copy of Protecting Lives, Preventing HIV meeting report.